Kumari, A., Srivastava, S., Manne, R. K., Sisodiya, S., Santra, M. K., Guchhait, S. K., & Panda, D. (2019). C12, a combretastatin-A4 analog, exerts anticancer activity by targeting microtubules. Biochemical Pharmacology, 170, 113663–113663. https://doi.org/10.1016/j.bcp.2019.113663

Kumari, Anuradha, Shalini Srivastava, Rajesh K. Manne, Shailendra Sisodiya, Manas K. Santra, Sankar K. Guchhait, and Dulal Panda. “C12, a combretastatin-A4 analog, exerts anticancer activity by targeting microtubules.” Biochemical Pharmacology 170 (December 2019): 113663–113663. https://doi.org/10.1016/j.bcp.2019.113663.

Kumari A, Srivastava S, Manne RK, Sisodiya S, Santra MK, Guchhait SK, et al. C12, a combretastatin-A4 analog, exerts anticancer activity by targeting microtubules. Biochemical Pharmacology. 2019 Dec;170:113663–113663.

Kumari, Anuradha, et al. “C12, a combretastatin-A4 analog, exerts anticancer activity by targeting microtubules.” Biochemical Pharmacology, vol. 170, Elsevier BV, Dec. 2019, pp. 113663–113663. Crossref, doi:10.1016/j.bcp.2019.113663.

Kumari A, Srivastava S, Manne RK, Sisodiya S, Santra MK, Guchhait SK, Panda D. C12, a combretastatin-A4 analog, exerts anticancer activity by targeting microtubules. Biochemical Pharmacology. Elsevier BV; 2019 Dec;170:113663–113663.